Free Consultations 24/7
Our law firm has been dedicated to clients like you for 90 years. We care about each one of our clients.
Cases We Handle
from auto accidents to defective product injuries to workers’ compensation claims, we’re here to help.
We value building relationships with the many people and organizations that make Cleveland a great place to live.
Our law firm has a trusted team of personal injury lawyers who have been helping injured people in Cleveland.
One of the leading causes of Drug Injury today is when a patient is given or takes too much of a medication that results in adverse health events. One of the drugs most commonly involved in these errors are prescription painkillers, which is why many citizens are concerned regarding the U. S. Food and Drug Administration’s (FDA) approval of a new, more powerful narcotic used to treat chronic pain.
According to an article from ABC 5 News, the new medication, called Zohydro, is said to be ten times stronger than the most powerful painkiller currently on the market, Oxycontin. This means taking two capsules of the new drug could cause an adult who is not used to taking such medications to overdose, and ingesting one pill could kill a child.
The potential for abuse, overdose, and injury has many drug safety organizations across the United States and in Ohio rallying to protest the release of the medication. Groups like Lorain County Alcohol & Drug Abuse Services, Inc. say they are closely monitoring the release of the drug and the affects it has on the community.
The Ohio Personal Injury Lawyers with Nurenberg, Paris, Heller & McCarthy recognize the potential dangers powerful narcotic medications can pose and encourage anyone prescribed such medications to ask plenty of questions of your physician, closely monitor your schedule of dosages, and seek medical attention if you begin to feel dependent on your medication.
As advancements in biomedical technology continue to create new opportunities for convenient and painless solutions, more and more products are…
The Journal of the American Medical Association (JAMA) Internal Medicine study, released this month, suggests that doctors should take greater…
Viekira Pak™ and Technivie™ Liver Damage In October, the U.S. Food and Drug Administration (FDA) issued a new warning regarding a potential…